Halitosis is a chronic breath problem affecting large number of people. Bad breath is a common problem that can cause significant psychological distress and there are a number of potential causes and treatments available.
Gradual increase in number of patients suffering from chronic halitosis and high spending by consumer on oral hygiene are major factors expected to drive the growth of global halitosis treatment market. Halitosis is a common condition of bad breath. Major cause of the chronic halitosis is diet issue, oral issue, and medical conditions. According to Bad Breath Institute, researchers estimate that over 80 million Americans suffer from chronic halitosis. At least 99% of everyone else has “dragon breath” in the morning. Consumers are spending high in oral hygiene products in order to feel fresh. Each year, Americans spend over US$10 Bn on oral hygiene products (i.e. gums, mouthwashes, toothpastes, etc.) to combat chronic bad breath. Major players are focused on introduction of new products in order to attract customers this is expected to augment the growth of halitosis treatment market. In 2020, Johnson & Johnson Consumer, Inc., a global manufacturer of consumer products launched LISTERINE® READY! TABS™, Clean Mint solid-to-liquid tablets for bad breath. This product launch is expected to help the company to enhance the customer base. In addition, major players are spending high on R&D activities; considering the consumers interest towards adoption of Ayurvedic and alcohol free products is forcing players to cater the changing demand.
In 2021, Dabur India Ltd. a consumer product manufacturer launched “Dabur Red Pulling Oil” an Ayurvedic mouthwash creating a whole new category in oral care. This product launch is expected to help company to enhance the product portfolio and increase the customer base.
In 2021, BIOAYURVEDA, another consumer product manufacturer launched Anti-Bacterial Germ Defense Mouth Wash. The product is prepared with pure organics and no alcohol; this is expected to attract customers preferring non-alcoholic products.
Rising geriatric population across the globe, coupled with increase in old age problems causing bad breath is resulting in demand for drugs such as antiseptics and antacids this is expected to impact the growth of global halitosis treatment market. Government of developing countries is focused on strengthening the regional manufacturing capabilities. Availability of favorable business policies from the government and surfacing of mid-size enterprises with new innovative products is expected to boost the global halitosis treatment market growth. Factors such as lack of awareness among consumers and complex regulations by the government for product approval are factors expected to hamper the growth of global halitosis treatment market. In addition, lack of strong distribution channel is limiting the adoption of products further challenging the growth of target market. However, increasing R&D activities by major players, introduction of new herbal products and focus on strengthening the distribution channel are factors expected to create new opportunities for players operating in halitosis treatment market over the forecast period. In addition, increasing business development activities by major players through mergers & acquisitions is expected to support the revenue transaction of the target market.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the global halitosis treatment market due to large number of patients suffering from chronic halitosis. Availability of advanced infrastructure for R&D activities and favorable reimbursement policies are factors expected to support the regional growth. In addition, high presence of players operating in the country such as US and introduction of innovative solutions is expected to support the growth of halitosis treatment market.
The global halitosis treatment market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Halitosis Treatment Market Segment Analysis, 2019
The global halitosis treatment market is segmented into type, indication, diagnostic test, and drug treatment. The type segment is bifurcated into pathological halitosis and physiological halitosis. Among type, the pathological halitosis segment is expected to account for major revenue share in the global halitosis treatment market. The drug treatment segment is divided into antiseptics, antacids, ranitidine, and others. Among drug treatment, the antacids segment is expected to account for a noticeable revenue share in target market. The players profiled in the report are Colgate-Palmolive Company, All USA Partners LLC, Dr. Harold Katz, LLC, Rowpar Pharmaceuticals, Inc., Abbott, Listerine, and AstraZeneca.
Market By Type
Market By Indication
Market By Diagnostic Test
β-galactosidase activity assay
Market By Drug Treatment
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Gradual increase in number of patients suffering from chronic halitosis and high spending by consumer on oral hygiene are major factors expected to drive the growth of global halitosis treatment market.
In type the pathological halitosis segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are Colgate-Palmolive Company, All USA Partners LLC, and Dr. Harold Katz, LLC.
The North America is expected to account for major revenue share in the global market.
In drug treatment the antacids segment is growing at faster pace.
Factors such as lack of awareness among consumers and complex regulations by the government for product approval are factors expected to hamper the growth of global halitosis treatment market.